SCHEMBL2507012

SCHEMBL2507012

CCCCc1cc(C(C)(C)CC(C)(C)C)cc(OC(=O)c2ccccc2)c1OC(=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.40
MAPT P10636 3/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
ELANE P08246 1/20 0.36
ALOX5 P09917 2/20 0.35
SLC6A3 Q01959 2/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34
SCN1A P35498 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
MEN1 O00255 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2888400 0.93 NPSR1 (0.41) NPSR1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL2482843 0.90 KMT2A (0.41) NPSR1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL2480430 0.89 NPSR1 (0.48) NPSR1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL2888081 0.83 NPSR1 (0.38) NPSR1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL2886891 0.83 KMT2A (0.43) NPSR1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL2478898 0.82 NPSR1 (0.50) NPSR1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL2481425 0.80 KMT2A (0.43) MAPTKMT2ASMN1; SMN2TDP1L3MBTL1
SCHEMBL2506286 0.80 KMT2A (0.43) NPSR1MAPTKMT2ASMN1; SMN2TDP1
SCHEMBL2480370 0.80 LMNA (0.41) MAPTKMT2ASMN1; SMN2TDP1L3MBTL1
SCHEMBL2888364 0.80 MAPT (0.40) NPSR1MAPTKMT2ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT NPSR1 2230/4885MAPT 2384/4885KMT2A 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.